These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25678176)

  • 21. Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
    Novick D; Ascher-Svanum H; Brugnoli R; Bertsch J; Hong J; Haro JM
    J Nerv Ment Dis; 2012 Jul; 200(7):637-43. PubMed ID: 22759944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.
    Bazo-Alvarez JC; Morris TP; Carpenter JR; Hayes JF; Petersen I
    J Psychopharmacol; 2020 Jan; 34(1):79-85. PubMed ID: 31724905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
    Osborn DP; Petersen I; Beckley N; Walters K; Nazareth I; Hayes J
    J Psychopharmacol; 2018 Oct; 32(10):1098-1103. PubMed ID: 29938561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching elderly patients with dementia from risperidone to quetiapine: a retrospective study.
    Madhusoodanan S; Bogunovic O
    Am J Alzheimers Dis Other Demen; 2006; 21(3):169-74. PubMed ID: 16869337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
    Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
    Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
    J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006.
    Hilwerling L; Juckel G; Schröder SG
    Int J Geriatr Psychiatry; 2007 May; 22(5):401-4. PubMed ID: 17096460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial.
    Katz IR; Rupnow M; Kozma C; Schneider L
    Am J Geriatr Psychiatry; 2004; 12(5):499-508. PubMed ID: 15353388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment changes among older patients with dementia treated with antipsychotics.
    Kim HM; Chiang C; Weintraub D; Schneider LS; Kales H
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1238-49. PubMed ID: 25759986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.
    Sanfélix-Gimeno G; Cervera-Casino P; Peiró S; López-Valcarcel BG; Blázquez A; Barbera T
    Drug Saf; 2009; 32(11):1075-87. PubMed ID: 19810779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.
    Okumura Y; Togo T; Fujita J
    Int Psychogeriatr; 2015 Mar; 27(3):407-15. PubMed ID: 25213318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly.
    Laks J; Engelhardt E; Marinho V; Rozenthal M; Souza FC; Bacaltchuk J; Stoppe A; Ferreira RC; Bottino C; Scalco M
    Arq Neuropsiquiatr; 2001 Dec; 59(4):859-64. PubMed ID: 11733828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.